Gladius Capital Management LP Royalty Pharma PLC Transaction History

Gladius Capital Management LP

  • $166 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024
BUY
$26.26 - $29.9 $31,722 - $36,119
1,208 New
1,208 $31,000
Q2 2022

Aug 10, 2022
SELL
$37.53 - $44.22 $102,719 - $121,030
-2,737 Reduced 74.6%
932 $40,000
Q1 2022

Apr 29, 2022
BUY
$37.46 - $42.44 $137,440 - $155,712
3,669 New
3,669 $143,000

Others Institutions Holding RPRX

# of Institutions
410
Shares Held
284M
Call Options Held
578K
Put Options Held
47.5K
View Full List

About Royalty Pharma plc

RPRX Quotes by TradingView
  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $13.4B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Gladius Capital Management LP Portfolio

Follow Gladius Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gladius Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Gladius Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email